antimony has been researched along with Canine Diseases in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (50.00) | 18.7374 |
| 1990's | 7 (35.00) | 18.2507 |
| 2000's | 2 (10.00) | 29.6817 |
| 2010's | 1 (5.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castanys, S; Corpas-López, V; Gamarro, F; García-Hernandez, R; Gómez Pérez, V; Martín-Sanchez, J; Tomás, AM | 1 |
| GENET, L | 1 |
| MARKIEWICZ, K; STANKIEWICZ, W | 1 |
| MANN, PH | 1 |
| Alving, CR; Chapman, WL; Hanson, WL; Hendricks, LD | 1 |
| Broxup, B; Ege, GN; Harauz, G; Leger, L; Norris, AM; Valli, VE | 1 |
| Closa, JM; Font, A; Gines, C; Mascort, J | 1 |
| Alberola, J; Arboix, M; Esteban, M; Valladares, JE | 1 |
| Slappendel, RJ; Teske, E | 1 |
| Amusategui, I; Sainz, A; Tesouro, MA | 2 |
| Belloli, C; Bertini, S; Carli, S; Crescenzo, G; Mengozzi, G; Ormas, P; Zaghini, A | 1 |
| Alunda, JM; Cuquerella, M; de la Fuente, C; Fernández-Pérez, FJ; Gómez-Muñoz, MT; Méndez, S | 1 |
| Alberola, J; Arboix, M; Díez-Cascón, A; Gállego, M; González-Ensenyat, P; Portús, M; Ramos, G; Riera, C; Solano-Gallego, L; Valladares, JE | 1 |
| Carrió, J; Portús, M | 1 |
| Oehme, FW | 1 |
| Coutinho, SG; Grimaldi, G; Marzochi, MC; Nunes, MP; Pirmez, C | 1 |
| Otto, GF | 1 |
| Fruin, J; Nicoletti, P | 1 |
| Malamos, B | 1 |
2 trial(s) available for antimony and Canine Diseases
| Article | Year |
|---|---|
The effect of intravenous or subcutaneous administration of meglumine antimonate (Glucantime) in dogs with leishmaniasis. A randomized clinical trial.
Topics: Animals; Antimony; Antiprotozoal Agents; Disease-Free Survival; Dog Diseases; Dogs; Female; Injections, Intravenous; Injections, Subcutaneous; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Remission Induction; Treatment Outcome | 1997 |
Long term improvement in the treatment of canine leishmaniosis using an antimony liposomal formulation.
Topics: Animals; Antimony; Delayed-Action Preparations; Dog Diseases; Dogs; Leishmaniasis; Liposomes; Male | 2001 |
18 other study(ies) available for antimony and Canine Diseases
| Article | Year |
|---|---|
Decreased antimony uptake and overexpression of genes of thiol metabolism are associated with drug resistance in a canine isolate of Leishmania infantum.
Topics: Animals; Antimony; Antiprotozoal Agents; Aquaglyceroporins; Dog Diseases; Dogs; Drug Resistance; Gene Expression; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasitic Sensitivity Tests; Sulfhydryl Compounds | 2016 |
[Cure in a case of leishmaniasis].
Topics: Animals; Antimony; Dog Diseases; Dogs; Leishmaniasis | 1952 |
[Attempted fuadin therapy of demodicidosis in dogs].
Topics: Animals; Antimony; Benzenesulfonates; Dog Diseases; Dogs; Mite Infestations; Organometallic Compounds | 1958 |
Determination of the antheimintic action of anthiomaline and piperazine HCl following intravenous injections into dogs.
Topics: Animals; Antimony; Dog Diseases; Dogs; Injections, Intravenous; Organometallic Compounds; Piperazine; Piperazines | 1959 |
Antileishmanial activity of liposome-encapsulated meglumine antimonate in the dog.
Topics: Animals; Antimony; Antiprotozoal Agents; Dog Diseases; Dogs; Leishmania; Leishmaniasis, Visceral; Liposomes; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1984 |
Lymphoscintigraphy in canine mammary neoplasia.
Topics: Animals; Antimony; Dog Diseases; Dogs; Female; Lymph Nodes; Lymphatic Metastasis; Lymphoscintigraphy; Male; Mammary Glands, Animal; Neoplasms; Technetium; Technetium Compounds | 1982 |
Visceral leishmaniasis and disseminated intravascular coagulation in a dog.
Topics: Animals; Antimony; Antiprotozoal Agents; Disseminated Intravascular Coagulation; Dog Diseases; Dogs; Female; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1994 |
Disposition of antimony after the administration of N-methylglucamine antimoniate to dogs.
Topics: Animals; Antimony; Antiprotozoal Agents; Biological Availability; Dog Diseases; Dogs; Half-Life; Injections, Intramuscular; Injections, Intravenous; Injections, Subcutaneous; Leishmania donovani; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1996 |
Effects of antimonial therapy for canine leishmaniasis on antibody titer.
Topics: Allopurinol; Animals; Antibodies, Protozoan; Antimony; Antiprotozoal Agents; Dog Diseases; Dogs; Fluorescent Antibody Technique, Indirect; Follow-Up Studies; Injections, Intramuscular; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Regression Analysis; Time Factors | 1998 |
Evolution of serum albumin/globulin ratio after antimonial therapy in canine leishmaniasis.
Topics: Allopurinol; Animals; Antimony; Antiprotozoal Agents; Dog Diseases; Dogs; Follow-Up Studies; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Regression Analysis; Serum Albumin; Serum Globulins; Time Factors | 1998 |
Disposition of antimony and aminosidine combination after multiple subcutaneous injections in dogs.
Topics: Amebicides; Animals; Antimony; Antiprotozoal Agents; Area Under Curve; Chromatography, Liquid; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Fluorometry; Half-Life; Injections, Subcutaneous; Least-Squares Analysis; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Paromomycin; Spectrophotometry, Atomic | 1999 |
Short report: improved diagnosis and follow-up of canine leishmaniasis using amastigote-based indirect immunofluorescence.
Topics: Allopurinol; Animals; Antibodies, Protozoan; Antimetabolites; Antimony; Dog Diseases; Dogs; Fluorescent Antibody Technique, Indirect; Follow-Up Studies; Leishmania infantum; Leishmaniasis, Visceral | 1999 |
In vitro susceptibility to pentavalent antimony in Leishmania infantum strains is not modified during in vitro or in vivo passages but is modified after host treatment with meglumine antimoniate.
Topics: Animals; Antimony; Antiprotozoal Agents; Dog Diseases; Dogs; Drug Resistance; Humans; Leishmania infantum; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasitic Sensitivity Tests | 2002 |
Laboratory diagnosis of chemical intoxications.
Topics: Aflatoxins; Animals; Antimony; Arsenic Poisoning; Aspirin; Cat Diseases; Cats; Dog Diseases; Dogs; Mercury Poisoning; Phenols; Poisoning; Specimen Handling; Thallium | 1976 |
Canine American cutaneous leishmaniasis: a clinical and immunological study in dogs naturally infected with Leishmania braziliensis braziliensis in an endemic area of Rio de Janeiro, Brazil.
Topics: Animals; Antibodies, Protozoan; Antimony; Brazil; Dog Diseases; Dogs; Female; Fluorescent Antibody Technique; Follow-Up Studies; Leishmania braziliensis; Leishmaniasis, Mucocutaneous; Male; Skin Tests | 1988 |
Chemotherapeutic agents.
Topics: Animals; Antimony; Antiprotozoal Agents; Benzenesulfonates; Diethylcarbamazine; Dirofilariasis; Dithiazanine; Dog Diseases; Dogs | 1969 |
Treatment of canine cutaneous leishmaniasis.
Topics: Abscess; Animals; Antimony; Antiprotozoal Agents; Dog Diseases; Dogs; Injections, Intramuscular; Leishmania; Leishmaniasis, Mucocutaneous; Skin Diseases; Sodium | 1974 |
[Leishmaniasis (kala-azar, oriental sore, South American leishmaniasis)].
Topics: Adult; Animals; Antimony; Child; Diagnosis, Differential; Diptera; Disease Vectors; Dog Diseases; Dogs; Female; Humans; Leishmaniasis, Mucocutaneous; Leishmaniasis, Visceral; Male; Tropical Climate | 1967 |